| 858 | 4 | 191 |
| 下载次数 | 被引频次 | 阅读次数 |
妊娠胚物残留（RPOC）是指流产或分娩后，胚胎组织或胎盘未能完全排出而残留子宫内，可引起出血、感染，甚至宫腔粘连等。目前RPOC的治疗策略主要分为药物治疗和手术治疗两类，但国内外对此尚未形成科学、规范的指导意见。中西医联合诊治一直是我国诊治RPOC的特色手段，为推广中西医结合协同诊疗理念，促进RPOC中西医结合诊疗技术发展，山东中医药学会妇科专业委员会、山东中西医结合学会生殖外科专业委员会、山东省疼痛医学会妇产科专业委员会共同牵头成立共识专家组，讨论形成《中西医结合诊治妊娠胚物残留专家共识（2024年版）》，从RPOC的高危因素、临床表现、诊断、治疗等方面阐述中西医结合协同诊疗理念，并提供专家共识，以改善RPOC患者预后，提高其生活质量。
Abstract：Retained products of conception(RPOC) refers to the situation where embryonic tissue or placenta fails to be fully expelled from the uterus after an abortion or delivery,which can lead to bleeding,infection,and even adhesion of the uterine cavity. Currently,the treatment strategies for RPOC mainly consist of drug therapy and surgical treatment,but there is no scientific and standardized guidance on this issue at home or abroad. The integration of traditional Chinese medicine(TCM) and western medicine has always been a distinctive approach in the diagnosis and treatment of RPOC in China. In order to promote the concept of integrative TCM and western medicine treatment and promote the development of TCM and western medicine combined diagnosis and treatment for RPOC,the Gynecology Professional Committee of Shandong Association of Chinese Medicine,the Reproductive Surgery Professional Committee of Shandong Association of Integrated Traditional Chinese and Western Medicine,and the Obstetrics and Gynecology Professional Committee of Shandong Association of Pain Medicine have jointly formed a consensus expert group to discuss and formulate the Expert Consensus on Diagnosis and Treatment of Retained Products of Conception by Integrated Traditional Chinese and Western Medicine(2024 Edition). The consensus expert group provides expert consensus on the high-risk factors,clinical manifestations,diagnosis,and treatment of RPOC from the perspective of integrative TCM and western medicine treatment,with the aim of improving the prognosis and life quality of RPOC patients.
[1] BORTOLETTO P,ROMANSKI P A,SCHATZ-SIEMERS N,et al. Retained products of conception as an aetiology for endometritis[J]. BJOG,2022,129(2):185-187.
[2] SMORGICK N,SEGAL H,EISENBERG N,et al. Serumβ-HCG level in women diagnosed as having retained products of conception:a prospective cohort study[J]. J Minim Invasive Gynecol,2022,29(3):424-428.
[3] RAZ N,SIGAL E,GONZALEZ ARJONA F,et al. Seeand-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception:a retrospective study[J]. J Obstet Gynaecol Res,2022,48(9):2459-2465.
[4] LEVINSOHN-TAVOR O,SHARON N Z,FELDMAN N,et al. Managing patients with suspected postpartum retained products of conception using a novel sonographic classification[J]. Acta Radiol,2022,63(3):410-415.
[5] GRANFORS M,SANDSTR?M A,STEPHANSSON O,et al. Placental location and risk of retained placenta in women with a previous cesarean section:a populationbased cohort study[J]. Acta Obstet Gynecol Scand,2020,99(12):1666-1673.
[6]汤若楠，张琬琳，肖西峰，等.脂肪干细胞治疗宫腔粘连的研究进展[J].生殖医学杂志，2023,32(9):1446-1450.
[7] VELEBIL P,HYMPANOVA L H,HERMAN H,et al.Retained products of conception-a retrospective analysis of 200 cases of surgical procedures for the diagnosis of residua postpartum[J]. Ginekol Pol,2023,94(12):967-971.
[8] YAGUR Y,JURMAN L,WEITZNER O,et al. Ultrasound for diagnosis of postpartum retained products of conception-How accurate we are?[J]. BMC Pregnancy Childbirth,2023,23(1):572.
[9] DURFEE S M,FRATES M C,LUONG A,et al. The sonographic and color Doppler features of retained products of conception[J]. J Ultrasound Med,2005,24(9):1181-1186,1188-1189.
[10] PATHER S,FORD M,REID R,et al. Postpartum curettage:an audit of 200 cases[J]. Aust N Z J Obstet Gynaecol,2005,45(5):368-371.
[11] TOHMA Y A,DILBAZ B,EVLIYAO?LU?，et al. Is ultrasonographic evaluation essential for diagnosis of retained products of conception after surgical abortion?[J]. J Obstet Gynaecol Res,2016,42(5):489-495.
[12] WONG S F,LAM M H,HO L C. Transvaginal sonography in the detection of retained products of conception after first-trimester spontaneous abortion[J]. J Clin Ultrasound,2002,30(7):428-432.
[13] HAMEL C C,VAN WESSEL S,CARNEGY A,et al.Diagnostic criteria for retained products of conceptiona scoping review[J]. Acta Obstet Gynecol Scand,2021,100(12):2135-2143.
[14] ALCáZAR J L,BALDONADO C,LAPARTE C. The reliability of transvaginal ultrasonography to detect retained tissue after spontaneous first-trimester abortion,clinically thought to be complete[J]. Ultrasound Obstet Gynecol,1995,6(2):126-129.
[15] ALONSO PACHECO L,TIMMONS D,SAAD NAGUIB M,et al. Hysteroscopic management of retained products of conception:a single center observational study[J]. Facts Views Vis Obgyn,2019,11(3):217-222.
[16] SHITANAKA S,CHIGUSA Y,KAWAHARA S,et al.Conservative management for retained products of conception after less than 22 weeks of gestation[J]. J Obstet Gynaecol Res,2020,46(10):1982-1987.
[17] EL-BARADIE S M Y,EL-SAID M H,RAGAB W S,et al. Endometrial thickness and serum beta-hCG as predictors of the effectiveness of oral misoprostol in early pregnancy failure[J]. J Obstet Gynaecol Can,2008,30(10):877-881.
[18]张巧，张师前，周丹，等.早期妊娠相关子宫动静脉瘘诊治的中国专家共识（2022年版）[J].中国实用妇科与产科杂志，2022,38(3):284-289.
[19] HAN L,SHI G,ZHENG A,et al. Hysteroscopy for retained products of conception:a single-institution experience[J]. BMC Womens Health,2023,23(1):25.
[20] GAO F,MA X,XU Y,et al. Management of acquired uterine arteriovenous malformations associated with retained products of conception[J]. J Vasc Interv Radiol,2022,33(5):547-553.
[21] DAMIANI G R,DI GENNARO D,VIMERCATI A,et al.Office intrauterine morcellation for retained products of conception[J]. Minim Invasive Ther Allied Technol,2023,32(6):323-328.
[22]李雨霄.加减血府逐瘀汤治疗药物流产不全的临床疗效研究[D].保定：河北大学，2023.
[23]杨银.中药联合耳穴压豆治疗药流后阴道流血的临床观察[D].南昌：江西中医药大学，2023.
[24]叶智.加味下瘀血汤治疗瘀阻胞宫型药流不全的临床疗效观察[D].杭州：浙江中医药大学，2022.
[25]靖学锋.内服中药联合穴位贴敷治疗产后胎膜残留的临床研究[D].济南：山东中医药大学，2019.
[26]范晓艳.自拟血竭逐瘀缩宫汤治疗药物流产后宫腔残留的疗效观察[D].杭州：浙江中医药大学，2023.
[27]刘羽，靳琳.中药治疗失血性休克的体会[J].北京中医药大学学报，2003,26(2):70.
[28]邓志杰，董子洵，刘家伟，等.参附注射液综合评价研究[J].中国临床药理学杂志，2023,39(24):3682-3692.
[29]国家中医心血管病临床医学研究中心，中国医师协会中西医结合医师分会，《生脉类注射剂临床应用中国专家共识》编写组.生脉类注射剂临床应用中国专家共识[J].中国中西医结合杂志，2020,40(12):1430-1438.
[30]邢庆昌，张立俭，胡森.中医药治疗失血性休克的研究述评[J].中医学报，2011,26(6):730-732.
[31]曹小丽.针刺合谷、三阴交、太冲对初产妇产程影响的临床研究[D].兰州：甘肃中医药大学，2023.
[32]韦柳溢，郝二伟，侯小涛，等.薏苡附子败酱散的临床应用与药理作用研究进展[J].中国中药杂志，2023,48(18):4893-4901.
[33] TAKAHASHI H,OHHASHI M,BABA Y,et al. Conservative management of retained products of conception in the normal placental position:a retrospective observational study[J]. Eur J Obstet Gynecol Reprod Biol,2019,240:87-92.
[34] FORESTE V,GALLO A,MANZI A,et al. Hysteroscopy and retained products of conception:an update[J]. Gynecol Minim Invasive Ther,2021,10(4):203-209.
[35] GREWAL K,AL-MEMAR M,FOURIE H,et al. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage[J]. Ultrasound Obstet Gynecol,2020,55(5):676-682.
[36]中华医学会计划生育学分会.不全流产保守治疗专家共识[J].中华生殖与避孕杂志，2019,39(5):345-348.
[37]曾令芳，陈敏，吴玮，等.桂枝茯苓胶囊联合戊酸雌二醇治疗产后胎盘残留临床研究[J].中华中医药学刊，2023,41(5):62-66.
[38]方鸿浩，黄楠，陈香军.加味复方生化汤联合缩宫素对产后胎盘胎膜小部分残留患者产后出血量、子宫复旧及残留物变化的临床疗效观察[J].中华中医药学刊，2023,42(3):235-238.
[39]薛淑文.加味生化汤联合米非司酮治疗产后胎盘残留93例临床观察[J].湖南中医杂志，2022,38(2):10-13.
[40]张玉霞.米非司酮与复方中药联合米非司酮在人工流产后宫腔残留的临床效果对比分析[J].中医临床研究，2019,11(6):134-136.
[41]胡晓丹.补脾益肾调经汤治疗人流术后子宫内膜修复的临床疗效研究[D].南宁：广西中医药大学，2024.
[42] BEAMAN J,PRIFTI C,SCHWARZ E B,et al. Medication to manage abortion and miscarriage[J]. J Gen Intern Med,2020,35(8):2398-2405.
[43] HENKEL A,SHAW K A. Advances in the management of early pregnancy loss[J]. Curr Opin Obstet Gynecol,2018,30(6):419-424.
[44]王亮，曾玉，孙萌.中医护理在缓解子宫全切患者术前焦虑中的应用观察[J].光明中医，2020,35(4):603-605.
[45]黄媛，胡佩欣，钟淑琴，等.耳穴压豆缓解围手术期患者焦虑作用的Meta分析[J].广州中医药大学学报，2023,40(3):769-776.
[46] BAE H,BAE H,MIN B I,et al. Efficacy of acupuncture in reducing preoperative anxiety:a meta-analysis[J].Evid Based Complement Alternat Med,2014,2014:850367.
[47]梁花花，王亚军.近10年国内外针刺治疗焦虑症研究进展[J].中华中医药杂志，2019,34(3):1131-1133.
[48]卫勇平，张静喆.中医药疗法在术前焦虑治疗中的应用评价[J].上海中医药杂志，2012,46(6):3-5.
[49]王丹丹，李紫红，聂诗龙.耳穴压豆缓解手术患者术前焦虑的临床观察[J].内蒙古中医药，2023,42(11):90-92.
[50]陈雄为，王萍，林江海，等.颊针疗法在经皮椎体成形术术前镇痛中的应用研究[J].浙江中医杂志，2024,59(2):173-174.
[51]张倩，张旭东，苏帆.颊针于围手术期的应用[J].光明中医，2023,38(18):3676-3679.
[52]山东中西医结合学会妇科肿瘤专业委员会，山东中西医结合学会麻醉与镇痛专业委员会.妇科围手术期加速康复的中西医治疗专家共识[J].山东中医杂志，2021,40(6):543-551.
[53] COHEN S B,KALTER-FERBER A,WEISZ B S,et al.Hysteroscopy may be the method of choice for management of residual trophoblastic tissue[J]. J Am Assoc Gynecol Laparosc,2001,8(2):199-202.
[54] WESTENDORP I C,ANKUM W M,MOL B W,et al.Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion[J]. Hum Reprod,1998,13(12):3347-3350.
[55] WAGENAAR L P,HAMERLYNCK T W,RADDER C M,et al. Hysteroscopic morcellation vs. curettage for removal of retained products of conception:a multicenter randomized controlled trial[J]. Fertil Steril,2023,120(6):1243-1251.
[56] NIR A,MOR M,YEKUTIEL M,et al. Postpartum retained products of conception:Is it possible to avoid postpartum curettage?[J]. Int J Gynecol Obstet,2022,156(2):231-235.
[57] HOOKER A B,AYDIN H,BR?LMANN H A M,et al.Long-term complications and reproductive outcome after the management of retained products of conception:a systematic review[J]. Fertil Steril,2016,105(1):156-164.
[58] BEN-AMI I,MELCER Y,SMORGICK N,et al. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception[J]. Int J Gynaecol Obstet,2014,127(1):86-89.
[59] CAPMAS P,LOBERSZTAJN A,DUMINIL L,et al. Operative hysteroscopy for retained products of conception:efficacy and subsequent fertility[J]. J Gynecol Obstet Hum Reprod,2019,48(3):151-154.
[60] REIN D T,SCHMIDT T,HESS A P,et al. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage[J]. J Minim Invasive Gynecol,2011,18(6):774-778.
[61] GOLAN A,DISHI M,SHALEV A,et al. Operative hysteroscopy to remove retained products of conception:novel treatment of an old problem[J]. J Minim Invasive Gynecol,2011,18(1):100-103.
[62] ANSARI S H,BIGATTI G,AGHSSA M M. Operative hysteroscopy with the Bigatti shaver(IBS?)for the removal of placental remnants[J]. Facts Views Vis Obgyn,2018,10(3):153-159.
[63] VAN WESSEL S,CORYN N,VAN VLIET H,et al.Reproductive and obstetric outcomes after hysteroscopic removal of retained products of conception[J].J Minim Invasive Gynecol,2020,27(4):840-846.
[64] MOHR-SASSON A,GUR T,MEYER R,et al. Office operative hysteroscopy for the management of retained products of conception[J]. Reprod Sci,2022,29(3):761-767.
[65]何小赟.针药联合雌孕激素序贯疗法对宫腔粘连术后患者子宫内膜的修复作用[J].浙江中医杂志，2021,56(3):186-187.
[66]刘桂香，熊娟，俞瑞琥.针药结合联合雌孕激素序贯疗法预防官腔粘连分解术后再粘连临床观察[J].安徽中医药大学学报，2017,36(5):49-52.
[67]孙爽.滋肾祛瘀养膜方联合耳穴压豆防治宫腔粘连（肾虚血瘀证）术后再复发的临床研究[D].沈阳：辽宁中医药大学，2023.
[68]唐诗，邢艺璇，吴阳，等.尤昭玲宫腔粘连-求子临证认知与诊疗策略[J].中华中医药杂志，2021,36(1):256-259.
[69]刘桓均，朱美琴，唐凤秀，等.针灸联合米非司酮治疗宫内组织物残留临床研究[J].四川中医，2022,40(4):194-197.
[70]王嫄.电针八髎在妇产科中的应用进展[J].中国医疗器械信息，2021,27(14):33-34,128.
[71]陈玲.生化汤加减联合温针灸对流产后宫腔残留患者宫内组织残留物及宫腔容积复旧的影响[J].江西中医药，2023,54(8):54-57.
[72]苏文武，招敏虹，潘清洁，等.电针八髎穴对不全流产清宫术后宫内组织物残留及宫腔容积复旧的影响[J].中国针灸，2021,41(8):871-875.
[73]陈嫚.低频电刺激联合补肾活血丸对人工流产术后子宫复旧的影响[D].南昌：江西中医药大学，2021.
基本信息:
DOI：10.16295/j.cnki.0257-358x.2025.01.001
中图分类号:R714.2
引用信息:
[1]王雅卓,王玉超,李雅琳,等.中西医结合诊治妊娠胚物残留专家共识（2024年版）[J].山东中医杂志,2025,44(01):1-11.DOI:10.16295/j.cnki.0257-358x.2025.01.001.
2025-01-05
2025-01-05